Chungwa Precision Test Tech. Co., Ltd. – Trademark Portfolio
Entity Type: 03
Chungwa Precision Test Tech. Co., Ltd. holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 1 filings in this category. The portfolio also extends into Class 9 (Computers & Electronics) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include CHPT. The owner is based in Taoyuan City 324.
No.15
Taoyuan City 324 , TW
Showing of trademarks Trademarks
Trademark Classifications
Chungwa Precision Test Tech. Co., Ltd.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Frequently Asked Questions
How many trademarks does Chungwa Precision Test Tech. Co., Ltd. have?
Chungwa Precision Test Tech. Co., Ltd. has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.
What trademark classes does Chungwa Precision Test Tech. Co., Ltd. file in?
Chungwa Precision Test Tech. Co., Ltd. files trademarks across 2 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 9 (Computers & Electronics). Class 42 covers scientific and technological services; industrial analysis and research services.
What are Chungwa Precision Test Tech. Co., Ltd.'s most well-known trademarks?
Chungwa Precision Test Tech. Co., Ltd.'s registered trademark portfolio includes well-known marks such as CHPT. These are among 2 currently registered trademarks in the portfolio.
What is Chungwa Precision Test Tech. Co., Ltd.'s trademark registration success rate?
Chungwa Precision Test Tech. Co., Ltd. has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.